Examining Real-World Persistence & Adherence to GLP-1s to Inform Payers & Improve Coverage
Time: 9:00 am
day: Conference Day One
Details:
- Uncovering data-driven insights into actual patient behavior with GLP-1 therapies, highlighting factors influencing adherence and persistence beyond clinical trial settings, to demonstrate the practical challenges and opportunities for improved patient management
- Showcasing how real-world data can be used to assess the long-term economic impact of GLP-1s, aiding payers in value-based purchasing negotiations and demonstrating the financial benefits of sustained treatment
- Exploring how real-world adherence data can guide the development of tailored patient support programs and interventions, leading to improved outcomes and justifying broader payer coverage by demonstrating enhanced patient benefit and treatment efficacy
